Skip to content
PoliticalRepoPoliticalRepo

Ireland · Question · written

PQ 268

268. Deputy David Cullinane asked the Minister for Health if she considers a restriction of over-the-counter low-dosage codeine-containing products to a prescription-only model to run contrary to the principles of the new pharmacy agreement and common conditions scheme; if she considers that new eprescribing and other pharmacy IT systems combined with the rollout of patient identifiers could serve as a control for access to codeine-containing products without the need to include GPs in low-to-moderate pain management beyond the role which they already serve; and if she will make a statement on the matter. [15418/26]

askedIreland· Dáil Éireann· EN

Introduced

25 February 2026

Last action

Status

written

Sponsors

Subjects

Discovery layer

Source updated

25 February 2026

Summary

268. Deputy David Cullinane asked the Minister for Health if she considers a restriction of over-the-counter low-dosage codeine-containing products to a prescription-only model to run contrary to the principles of the new pharmacy agreement and common conditions scheme; if she considers that new eprescribing and other pharmacy IT systems combined with the rollout of patient identifiers could serve as a control for access to codeine-containing products without the need to include GPs in low-to-moderate pain management beyond the role which they already serve; and if she will make a statement on the matter. [15418/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

Pharmacy Services

View fileDownload file

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.